Medpace
MEDP
67 hedge funds and large institutions have $184M invested in Medpace in 2016 Q3 according to their latest regulatory filings, with 67 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$29.8M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$20.4M |
| 3 |
HM
HealthCor Management
New York
|
+$9.54M |
| 4 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
+$9.52M |
| 5 |
Massachusetts Financial Services
Boston,
Massachusetts
|
+$9.01M |
Top Sellers
MEDP Hedge Fund Activity: Q3 2016 in Review
67 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Medpace (MEDP) for Q3 2016, worth a combined $184M.
Buyers outnumbered sellers: 67 funds opened new MEDP positions and 0 closed out — a net gain of 67 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Fidelity Investments, opening a new position worth an estimated $29.8M.
- 67 institutional investors held Medpace (MEDP) as of Q3 2016, up from 0 in Q2 2016.
- Funds reported $184M of Medpace stock for Q3 2016.
- 67 funds opened new Medpace positions in Q3 2016 and 0 closed out, a net change of +67 holders.
- The largest Medpace buyer in Q3 2016 was Fidelity Investments, an estimated $29.8M added.
Based on aggregated 13F filings for Q3 2016.